Natan Ponieman - Spark Newswire

2 minute read

Investment Banks Bullish On Psychedelics Co Atai Life Sciences: Cantor, Credit Suisse, Citigroup, Cowen, Aegis And Others Launch Coverage, Positive Ratings

Today, 12:08 PM

This week, a number of financial firms and investment banks initiated coverage of Atai Life Sciences (NASDAQ: ATAI), the Peter Thiel-backed biotech exploring a host of psychedelic compounds and treatments for use in mental health.

ATAI

1 minute read

Palo Santo: New Venture Capital Group Raises $35M To Focus On Psychedelic Medicine

By Natan Ponieman

Today, 12:08 PM

Palo Santo, a newly-created venture capital fund with an eye on psychedelic medicines, announced its official launch on Thursday.

ATAI

3 minute read

Psyched: Numinus, MindMed, Cybin Reach Milestones, Harvard To Study Psychedelics Law, Michael Pollan Dives Into Mescaline

By Natan Ponieman

Today, 12:08 PM

Michael Pollan’s New Book Takes A Deep Dive Into Mescaline – Will This Be A Turning Point For The Recognition And Study of Mescaline?

CLXPF

1 minute read

Columbia Care Launches Cannabis Cultivation Operations in West Virginia

By Natan Ponieman

Today, 12:08 PM

Cannabis multi-state operator Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) has received approval from West Virginia’s Office of Medical Cannabis to launch cultivation operations in the state.

CCHWF

5 minute read

Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies

By Natan Ponieman

Today, 12:08 PM

Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential of 5-MeO-DMT for the treatment of psychiatric and neurological disorders, is now listing its stock on the Nasdaq under the symbol “GHRS.”

BRAXF

6 minute read

Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More

By Natan Ponieman

Today, 12:08 PM

Institutional analysts are taking a liking to the industry of medicinal psychedelics. This week, investment bank Maxim Group initiated coverage of companies in the psychedelics space, giving a bullish Buy rating to all 10.

CLXPF

1 minute read

Compass Pathways Completes Target Administration Of Psilocybin Therapy In World’s Largest Study

By Natan Ponieman

Today, 12:08 PM

Compass Pathways (Nasdaq: CMPS), a biotech company in the psychedelics space, announced it has completed a key milestone on its path to obtaining FDA approval for psilocybin in the treatment of depression.

CMPS

2 minute read

Cybin Inc Biotech Co Reports $51 Million In Cash As Stifel Ups Price Target To $12

By Natan Ponieman

Today, 12:08 PM

Psychedelics companies continue to receive welcoming signs from Wall Street. As more companies commence their Nasdaq listings, investment banks are also jumping in with open arms.

CLXPF

2 minute read

Peter Thiel-backed Psychedelics Company Rings Nasdaq Bell: Atai Life Sciences Goes Public

By Natan Ponieman

Today, 12:08 PM

Atai Life Sciences (NASDAQ: ATAI), a biotech company in the psychedelic space, had its Nasdaq debut on Friday.

ATAI

1 minute read

Mydecine Innovations Group Launches AI-Assisted Drug Discovery Program

By Natan Ponieman

Today, 12:08 PM

Mydecine Innovations Group (NEO: MYCO) (OTCPINK: MYCOF), a biotech company in the psychedelics space, announced on Wednesday the launch of a virtual drug discovery program that will use artificial intelligence and machine learning to inform its drug discovery process.

MYCOF